Antimicrobial effects of nifuratel against Staphylococcus epidermidis by targeting proton motive force
Open Access
- 14 August 2026
- journal article
- research article
- Published by Springer Nature in AMB Express
- Vol. 16 (1)
Abstract
The increasing antimicrobial resistance of Staphylococcus epidermidis, a leading opportunistic pathogen causing device‑related and nosocomial infectiKeywords
Funding Information
- the Key Project of Science and Technology of China National Tobacco Corporation (No. 110202202025)
This publication has 41 references indexed in Scilit:
- Disease-associated genotypes of the commensal skin bacterium Staphylococcus epidermidisNature Communications, 2018
- Optimized arylomycins are a new class of Gram-negative antibioticsNature, 2018
- Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogensPLOS Pathogens, 2018
- Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coliDiagnostic Microbiology and Infectious Disease, 2018
- Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Depolarization of the Membrane Potential by β-Lactams as a Signal to Induce AutolysisBiochemical and Biophysical Research Communications, 2002
- Microbiological and Pharmaco-toxicological Profile of Nifuratel and its Favourable Risk/Benefit Ratio for the Treatment of Vulvo-vaginal InfectionsArzneimittelforschung, 2002
- Simulated in vitro Quinolone Pharmacodynamics at Clinically Achievable AUC/MIC Ratios: Advantage of IE over Other Integral ParametersChemotherapy, 2002
- Comparative Pharmacodynamics of Gatifloxacin and Ciprofloxacin in an In Vitro Dynamic Model: Prediction of Equiefficient Doses and the Breakpoints of the Area under the Curve/MIC RatioAntimicrobial Agents and Chemotherapy, 2000
- Comparative in vitro Activity of Five NitrofuransChemotherapy, 1978